Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4.
about
Lipidome in colorectal cancerLoss of Ypk1, the yeast homolog to the human serum- and glucocorticoid-induced protein kinase, accelerates phospholipase B1-mediated phosphatidylcholine deacylationAdvances in Lipidomics for Cancer Biomarkers DiscoveryThe expression profile of phosphatidylinositol in high spatial resolution imaging mass spectrometry as a potential biomarker for prostate cancerSignificantly increased monounsaturated lipids relative to polyunsaturated lipids in six types of cancer microenvironment are observed by mass spectrometry imaging.Enhanced specificity for phosphatidylcholine analysis by positive ion mode matrix-assisted laser desorption/ionization imaging mass spectrometry.In situ drug and metabolite analysis [corrected] in biological and clinical research by MALDI MS imaging.MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice.Imaging mass spectrometry increased resolution using 2-mercaptobenzothiazole and 2,5-diaminonaphtalene matrices: application to lipid distribution in human colon.Decreased level of phosphatidylcholine (16:0/20:4) in multiple myeloma cells compared to plasma cells: a single-cell MALDI-IMS approach.Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer.MALDI mass spectrometry imaging: A cutting-edge tool for fundamental and clinical histopathology.Phospholipids as cancer biomarkers: Mass spectrometry-based analysis.Accumulation of arachidonic acid-containing phosphatidylinositol at the outer edge of colorectal cancer.Plasma Phosphatidylcholines Fatty Acids in Men with Squamous Cell Esophageal Cancer: Chemoradiotherapy Improves Abnormal Profile.Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues.Visualization of sphingolipids and phospholipids in the fundic gland mucosa of human stomach using imaging mass spectrometry.Characterizing metabolic changes in human colorectal cancer.Essential Role of Lysophosphatidylcholine Acyltransferase 3 in the Induction of Macrophage Polarization in PMA-Treated U937 Cells.Mass spectrometry coupled to imaging techniques: the better the view the greater the challenge.The Distribution of Phosphatidylcholine Species in Superficial-Type Pharyngeal Carcinoma.Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer.Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis.Plasma Lipidomic Signature of Rectal Adenocarcinoma Reveals Potential Biomarkers.The stearate-to-palmitate ratio modulates endoplasmic reticulum stress and cell apoptosis in non-B non-C hepatoma cells.Analysis of the Lipid Profile in Patients with Colorectal Cancer in Advanced Stages
P2860
Q26766296-C96AB4D1-66FE-4801-ADBF-DD653ED77C2AQ27930785-70973DCA-354C-45C2-8A48-DA3484D0B1E9Q28079507-64EAC70C-F44E-492D-9373-C6A2669CFFD8Q28540259-AADB9366-A47B-4B98-B5AB-06859D2D2C6BQ34001479-83E0314E-5E68-427D-9EE1-98AE92051EADQ35174031-C72EDB08-9B9C-44CF-AD9A-3991CC185974Q35191571-83E65591-7CB1-4AC5-815C-F8D898F4A232Q35549222-05D4BFF7-D33E-4265-8F67-3C776E62CCB7Q35611870-9B9BEB8B-D1FA-451F-8565-5A94DA14E9CCQ35626025-2F168324-DAD7-4F98-9562-BA65DED2B0DEQ35762498-A6847E80-9339-454D-A667-D0BFE2305278Q36020378-9D117B7F-A44A-48E3-973A-053626780D7FQ36045221-54C45757-2334-4ECE-BB9E-60BEDB67A358Q36082169-A0FF4394-EFEF-4CB5-844E-AD0D64E23296Q37387806-FA6661B3-0BD4-44F8-9E01-9FDBA26B7058Q38638301-4ED78B63-6997-4FCC-8A3F-6FDCBB582B71Q39757812-19ED20A6-141F-4C50-920E-356C5E7E7A1DQ40974589-00BDDF5F-451B-44A1-8524-84381D08B960Q41212304-48AEAAEA-BAA1-4766-A33F-381DA6DD5797Q43115402-D9F831C1-B9E7-496B-ABE2-7C003891946CQ43161057-467F3D04-E739-4498-8606-46FD152C1AA9Q45258328-2F852FE4-7F1A-4BC7-B25B-93953ECC7114Q47574127-4168745B-E77A-403D-92DC-92E57AE23677Q48527663-00D7FD6F-4AB0-4A72-BA18-D97DB655DE33Q50088540-C124D136-E470-4ED0-BEA5-0931E4B310DEQ55646338-51CCA626-303E-43DC-8775-E9B7E32EC274
P2860
Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Accumulated phosphatidylcholin ...... ossible involvement of LPCAT4.
@ast
Accumulated phosphatidylcholin ...... ossible involvement of LPCAT4.
@en
Accumulated phosphatidylcholine
@nl
type
label
Accumulated phosphatidylcholin ...... ossible involvement of LPCAT4.
@ast
Accumulated phosphatidylcholin ...... ossible involvement of LPCAT4.
@en
Accumulated phosphatidylcholine
@nl
prefLabel
Accumulated phosphatidylcholin ...... ossible involvement of LPCAT4.
@ast
Accumulated phosphatidylcholin ...... ossible involvement of LPCAT4.
@en
Accumulated phosphatidylcholine
@nl
P2093
P356
P1433
P1476
Accumulated phosphatidylcholin ...... possible involvement of LPCAT4
@en
P2093
Haruhiko Sugimura
Kiyotaka Kurachi
Mikako Ogawa
Mitsutoshi Setou
Nobuya Kurabe
Noritaka Masaki
Takahiro Hayasaka
Tomoaki Kahyo
Toshio Nakamura
Yasuyuki Sugiyama
P304
P356
10.1111/CAS.12221
P577
2013-07-30T00:00:00Z